ClinicalTrials.Veeva

Menu

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

N

National Center for Research Resources (NCRR)

Status

Completed

Conditions

IGA Glomerulonephritis

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00004305
OSU-94H0338
199/11791

Details and patient eligibility

About

OBJECTIVES: I. Determine whether allelic differences associated with the fourth component of complement, type-1 complement receptor expressed on erythrocytes, and Fc receptor FcgRIII contribute to the pathogenesis of IgA glomerulonephritis (IgA-N).

II. Compare genetic anomalies of these key components in immune complex processing and clearance between juvenile vs adult onset IgA-N vs normal controls.

Full description

PROTOCOL OUTLINE:

Participants undergo qualitative genetic analysis of complement-related proteins. Studies include: genomic re-arrangement of 4-gene unit, C4 DNA sequence and RNA expression, type-1 complement receptor DNA sequence, Fc-gamma receptor IIIA isoform analysis, classical and alternative complement activation pathway assays, plasma C4 and C4d protein levels, and immunoglobulin patterns in glomerular deposits.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • IgA glomerulonephritis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems